[1]
Kolanchinathan, E., Harichandran, D.T., Balakrishnan, S.M. and Balakumaran, S.K.K. 2021. Adverse drug reactions to first line anti-tuberculosis drugs in newly diagnosed tuberculosis patients. International Journal of Basic & Clinical Pharmacology. 11, 1 (Dec. 2021), 65–69. DOI:https://doi.org/10.18203/2319-2003.ijbcp20214891.